Table 2.
Outcomes of motor performance assessment at baseline and postintervention.
| Outcome measure | Treatment group (n = 10) | Control group (n = 9) | Difference |
|---|---|---|---|
| P-valuea (η2 value)b | |||
| Upper extremity score via FMA | |||
| Baseline | 43.00 (9.82) | 45.44 (6.98) | |
| Postintervention | 52.20 (8.28) | 50.00 (8.82) | |
| Improvement | 9.20 (4.64) | 4.56 (2.60) | <0.01 (0.43) |
| AOU score via MAL | |||
| Baseline | 1.51 (0.78) | 1.40 (0.83) | |
| Postintervention | 2.61 (0.66) | 2.02 (0.70) | |
| Improvement | 1.10 (0.65) | 0.61 (0.85) | 0.02 (0.52) |
| QOM score via MAL | |||
| Baseline | 1.55 (0.77) | 1.33 (0.74) | |
| Postintervention | 2.55 (0.65) | 2.04 (0.68) | |
| Improvement | 1.10 (0.65) | 0.71 (0.72) | 0.07 (0.43) |
AOU, amount of use; FMA, Fugl-Meyer Assessment; MAL, Motor Activity Log; QOM quality of movement.
aBetween-group comparisons involved analysis of covariance.
bEffect size was assessed using the η2 value.